EQT
51
-3
RRC
52
-6
A
37
-2
VZ
44
4
LB
30
4
CSX
57
-4
TSCO
44
-4
PDCO
29
2
AME
74
-4
UPS
48
2
CTSH
60
-3
NOC
41
9
BEN
50
9
DFS
64
2
ORLY
60
-5
ZBH
65
3
HSIC
45
5
TXN
43
-5
TRIP
50
-4
NEE
54
7
EQT
51
-3
RRC
52
-6
A
37
-2
VZ
44
4
LB
30
4
CSX
57
-4
TSCO
44
-4
PDCO
29
2
AME
74
-4
UPS
48
2
CTSH
60
-3
NOC
41
9
BEN
50
9
DFS
64
2
ORLY
60
-5
ZBH
65
3
HSIC
45
5
TXN
43
-5
TRIP
50
-4
NEE
54
7
Financhill
Back

Creative Realities Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
16

CREX
Creative Realities

Last Price:
3.53
Seasonality Move:
14.61%
Sell
20

ALNY
Alnylam Pharmaceuticals

Last Price:
235.53
Seasonality Move:
10.85%
Sell
16
Creative Realities (CREX) is a Sell

Is Creative Realities a Buy, Sell or Hold?

  • The current Creative Realities [CREX] share price is $3.53. The Score for CREX is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • CREX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $235.56. The Score for ALNY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CREX Stock Price Chart

What is Creative Realities's stock price today?

  • The Creative Realities share price today is $3.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CREX is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $235.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

CREX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 34.34 Sell
Chaikin Money Flow: 23244 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.91 - 4.61) Sell
Bollinger Bands (100): (4.17 - 4.73) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.97 Sell
Relative Strength Index (14 RSI): 27.06 Sell
Chaikin Money Flow: -1631558 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (264.56 - 293.18) Sell
Bollinger Bands (100): (249.23 - 281.59) Sell

CREX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4 Sell
20-day SMA: 4.17 Sell
50-day SMA: 4.36 Sell
200-day SMA: 4.06 Sell
8-day EMA: 3.87 Sell
20-day EMA: 4.1 Sell
50-day EMA: 4.27 Sell
200-day EMA: 3.96 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 266.17 Sell
20-day SMA: 276.01 Sell
50-day SMA: 273.94 Sell
200-day SMA: 209.89 Buy
8-day EMA: 261.6 Sell
20-day EMA: 270.55 Sell
50-day EMA: 270.52 Sell
200-day EMA: 230.49 Buy

Creative Realities Earnings Growth & CREX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Creative Realities Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):